Floatz logo

Artiss

Breast Neoplasms

Mid and South Essex NHS Foundation TrustPhase 4 / ApprovedActive
B
58/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
54/ 100
Competitive Position
65/ 100

Competitive context

176 Active assets in the Breast Neoplasms cohort.

Asset / SponsorPhaseRating
Cyclophosphamide
Merck Sharp & Dohme LLC
Phase 4BB
Docetaxel
Universitas Airlangga
Phase 4BB
TAMOXIFEN
Eli Lilly and Company
Phase 3BB
Inno-206
Merck Sharp & Dohme LLC
Phase 4BB
Letrozole
Fujian Cancer Hospital
Phase 4BB

View all 50 →

Same molecule, other indications

Artiss is also rated in:

post-operative wound seroma, non-human animalDormant
BB
Indicative ·
69 / 100
View asset →
breast cancerDormant
B
Indicative ·
56 / 100
View asset →
aspiration pneumoniaDormant
NR
Indicative ·
/ 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →